Educational information only. Biomarker interpretation belongs in the right clinical or sports-science context; it is not an app-based clearance decision.

Blood tests and wearable metrics can look objective. They are still measurements taken at a particular time, under particular conditions, using a particular method.

The useful question is not “Which biomarker tells me whether I am ready?” It is “What does this measurement actually represent, and what other information does it need?”

CK is not a recovery clock

Creatine kinase can rise after strenuous exercise and muscle damage. The number is affected by the type of exercise, training history, muscle mass, timing, and individual response.

A high CK result does not automatically diagnose overtraining, and it does not measure brain injury. It should be interpreted by someone who understands the athlete’s history and the laboratory context.

Cortisol and stress markers have context

Cortisol and related endocrine measures can change with sleep, psychological stress, illness, nutrition, timing, and training. A single sample can be interesting without explaining the whole week.

The IOC consensus on load and illness supports a wider view that includes external work, internal response, health, and life context.

HRV is a trend, not a verdict

Heart-rate variability is sensitive to measurement conditions and the athlete’s state. The value usually comes from repeated measurements under consistent conditions, interpreted alongside sleep, perceived recovery, training load, and performance.

Low HRV does not prove overtraining. High HRV does not prove that hard contact or illness is safe to ignore.

Blood biomarkers and concussion research

GFAP, NfL, and other biomarkers are being studied in sport-related concussion research. The Amsterdam consensus describes advanced imaging, fluid biomarkers, genetic testing, and emerging technologies as valuable research tools that are not yet suited to routine use for all clinical recovery decisions.

The review of neurobiologic recovery biomarkers shows why the topic is promising and complicated: timing, trajectories, symptoms, cognitive performance, and clinical recovery do not always line up in a simple way.

Use measurements together

A sensible training review combines:

Recent external load
Sleep and perceived recovery
Illness, pain, stress, and nutrition
Repeated performance changes
Symptoms and the event timeline
Laboratory or wearable data when a qualified professional has a reason to use it

The IOC load-and-injury consensus emphasizes this kind of context. No single marker should carry the whole decision.

NeuroFight does not use blood biomarkers. It keeps training sessions, contact context, rolling load, notes, and personal cognitive-test trends visible so the athlete and coach can describe the week clearly.

Questions fighters ask

Does low HRV mean I am overtrained?

No. It is a context-sensitive signal. Look at the trend and the rest of the athlete’s week.

Does CK show whether my brain has recovered?

No. CK mainly reflects muscle-related processes and exercise response. It is not a brain-recovery test.

Can a blood test diagnose CTE?

No validated consumer blood test diagnoses CTE in a living fighter. Research markers should not be turned into a personal label.

Should I order a biomarker panel before every fight?

Only with a clear reason and appropriate professional guidance. More data is not automatically better data.

Sources

See NeuroFight on the App Store when you want the training context beside the measurements you already use.

TRAIN WITH CONTEXT

Keep the week visible.

NeuroFight helps combat athletes record training context and review daily guidance.

Download on the App Store

Athlete Biomarkers: What They Can and Cannot Tell You About Training